107 related articles for article (PubMed ID: 9553782)
1. Treatment of central nervous system inflammation with inhibitors of basement membrane degradation.
Parish CR; Hindmarsh EJ; Bartlett MR; Staykova MA; Cowden WB; Willenborg DO
Immunol Cell Biol; 1998 Feb; 76(1):104-13. PubMed ID: 9553782
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase.
Bartlett MR; Underwood PA; Parish CR
Immunol Cell Biol; 1995 Apr; 73(2):113-24. PubMed ID: 7797231
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the anti-inflammatory compounds heparin, mannose-6-phosphate, and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells, and platelets.
Bartlett MR; Cowden WB; Parish CR
J Leukoc Biol; 1995 Feb; 57(2):207-13. PubMed ID: 7852834
[TBL] [Abstract][Full Text] [Related]
4. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic use of gene therapy in inflammatory demyelinating diseases of the central nervous system.
Furlan R; Pluchino S; Martino G
Curr Opin Neurol; 2003 Jun; 16(3):385-92. PubMed ID: 12858077
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of adjuvant arthritis in the rat by phosphosugars and the alpha-glucosidase inhibitor castanospermine.
Willenborg DO; Parish CR; Cowden WB
Immunol Cell Biol; 1992 Dec; 70 ( Pt 6)():369-77. PubMed ID: 1289239
[TBL] [Abstract][Full Text] [Related]
7. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
8. Cytoskeleton networks in basement membrane transmigration.
Schoumacher M; Louvard D; Vignjevic D
Eur J Cell Biol; 2011; 90(2-3):93-9. PubMed ID: 20609495
[TBL] [Abstract][Full Text] [Related]
9. Cell surface expression of the 300 kDa mannose-6-phosphate receptor by activated T lymphocytes.
Hindmarsh EJ; Staykova MA; Willenborg DO; Parish CR
Immunol Cell Biol; 2001 Oct; 79(5):436-43. PubMed ID: 11564151
[TBL] [Abstract][Full Text] [Related]
10. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
11. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
12. An iminosugar-based heparanase inhibitor heparastatin (SF4) suppresses infiltration of neutrophils and monocytes into inflamed dorsal air pouches.
Sue M; Higashi N; Shida H; Kogane Y; Nishimura Y; Adachi H; Kolaczkowska E; Kepka M; Nakajima M; Irimura T
Int Immunopharmacol; 2016 Jun; 35():15-21. PubMed ID: 27015605
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system.
Auriel E; Regev K; Korczyn AD
Handb Clin Neurol; 2014; 119():577-84. PubMed ID: 24365321
[TBL] [Abstract][Full Text] [Related]
14. Molecular targets for disrupting leukocyte trafficking during multiple sclerosis.
McCandless EE; Klein RS
Expert Rev Mol Med; 2007 Jul; 9(20):1-19. PubMed ID: 17637110
[TBL] [Abstract][Full Text] [Related]
15. Matrix-specific protein kinase A signaling regulates p21-activated kinase activation by flow in endothelial cells.
Funk SD; Yurdagul A; Green JM; Jhaveri KA; Schwartz MA; Orr AW
Circ Res; 2010 Apr; 106(8):1394-403. PubMed ID: 20224042
[TBL] [Abstract][Full Text] [Related]
16. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity.
Benavente-García O; Castillo J
J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176
[TBL] [Abstract][Full Text] [Related]
17. Sulfated glycans in inflammation.
Pomin VH
Eur J Med Chem; 2015 Mar; 92():353-69. PubMed ID: 25576741
[TBL] [Abstract][Full Text] [Related]
18. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
19. Immune cell recruitment to inflammatory loci is impaired in mice deficient in basement membrane protein laminin alpha4.
Kenne E; Soehnlein O; Genové G; Rotzius P; Eriksson EE; Lindbom L
J Leukoc Biol; 2010 Sep; 88(3):523-8. PubMed ID: 20483922
[TBL] [Abstract][Full Text] [Related]
20. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
Eniola AO; Hammer DA
Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
